The Cholangiocarcinoma Foundation has put together several videos to help patients have a better understanding of biomarker testing, gene mutations, and clinical trials. Watch the videos and talk with your healthcare provider to discuss your treatment plan and care.
Biomarker testing is important for every cancer patient because it reveals details about a patient's cancer. Those details help patients and their doctors make personalized treatment decisions based on biomarkers detected. Biomarker testing also helps patients find clinical trials that they may join. Some trials enroll people based on the biomarkers in their cancer.
A mutation is a change in the DNA sequence of an organism. Mutations can result from errors in DNA replication during cell division, exposure to mutagens or a viral infection. Germline mutations (that occur in eggs and sperm) can be passed on to offspring, while somatic mutations (that occur in body cells) are not passed on. Cholangiocarcinoma is a rare disease, which makes understanding gene mutations extremely important.
Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device is safe and effective in people.